Major Private Equity Buyout Could Reshape UK Vet Medicine Supply
Animalcare, a significant supplier of veterinary pharmaceuticals in the UK, is set to be taken over by private equity firm Charterhouse in a deal worth around ยฃ235 million. Ownership changes at this scale in the vet medicines sector can influence product availability, pricing, and the range of treatments vets can offer. UK pet owners may want to monitor whether this consolidation affects access to medications their animals depend on.
Pet Gazette โ